Frequency of Gleason score 7 to 10 in 5100 elderly prostate cancer patients.

Reviews in urology Pub Date : 2016-01-01 DOI:10.3909/riu0732
N. Shah, V. Ioffe
{"title":"Frequency of Gleason score 7 to 10 in 5100 elderly prostate cancer patients.","authors":"N. Shah, V. Ioffe","doi":"10.3909/riu0732","DOIUrl":null,"url":null,"abstract":"Men 70 to 80 years of age are known to have an increased incidence of high-grade (Gleason sum score [GSS] 7-10) prostate cancer. We determined the frequency of highgrade prostate cancer among men 70 to 80 years old in our practice. We retrospectively reviewed our 5100 prostate cancer patients who are 70 to 80 years old and who opted for radiation therapy (external radiation, brachytherapy, or combination). Data were gathered on race, prostate-specific antigen value, digital rectal examination (DRE) results, and GSS. Patients were further subdivided by age in two categories, those 70 to 75 years and 76 to 80 years, and also by time period: 2006-2010 and 2011-2015. In patients 70 to 75 years, 1426 patients had a GSS of 6 (41%) and 2042 patients had a GSS of 7 to 10 (59%). In patients 76 to 80 years old, 553 had a GSS of 6 (34%) and 1079 had a GSS of 7 to 10 (66%). In 1432 patients with an abnormal DRE result, the GSS was 6 in 376 (26%) and GSS was 7 to 10 in 1059 (74%). Based on analysis of 5100 prostate cancer patients in our practice, we determined that 61% of patients age 70 to 80 have a high-grade prostate cancer, as do 59% of patients age 70 to 75 years, and 66% of patients between age 76 and 80 years. Because biopsy underestimates the grade in GSS 6 patients by 50%, the actual frequency is approximately 80%. In patients with prostate cancer who had an abnormal DRE result, 74% had a GSS of 7 to 10-approximately 85% when accounting for biopsy under-grading.","PeriodicalId":94353,"journal":{"name":"Reviews in urology","volume":"52 1","pages":"181-187"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3909/riu0732","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

Men 70 to 80 years of age are known to have an increased incidence of high-grade (Gleason sum score [GSS] 7-10) prostate cancer. We determined the frequency of highgrade prostate cancer among men 70 to 80 years old in our practice. We retrospectively reviewed our 5100 prostate cancer patients who are 70 to 80 years old and who opted for radiation therapy (external radiation, brachytherapy, or combination). Data were gathered on race, prostate-specific antigen value, digital rectal examination (DRE) results, and GSS. Patients were further subdivided by age in two categories, those 70 to 75 years and 76 to 80 years, and also by time period: 2006-2010 and 2011-2015. In patients 70 to 75 years, 1426 patients had a GSS of 6 (41%) and 2042 patients had a GSS of 7 to 10 (59%). In patients 76 to 80 years old, 553 had a GSS of 6 (34%) and 1079 had a GSS of 7 to 10 (66%). In 1432 patients with an abnormal DRE result, the GSS was 6 in 376 (26%) and GSS was 7 to 10 in 1059 (74%). Based on analysis of 5100 prostate cancer patients in our practice, we determined that 61% of patients age 70 to 80 have a high-grade prostate cancer, as do 59% of patients age 70 to 75 years, and 66% of patients between age 76 and 80 years. Because biopsy underestimates the grade in GSS 6 patients by 50%, the actual frequency is approximately 80%. In patients with prostate cancer who had an abnormal DRE result, 74% had a GSS of 7 to 10-approximately 85% when accounting for biopsy under-grading.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
5100例老年前列腺癌患者Gleason评分为7 ~ 10分的频率。
已知70至80岁的男性高级别(Gleason sum score [GSS] 7-10)前列腺癌的发病率增加。在我们的实践中,我们确定了70至80岁男性中高级别前列腺癌的发病率。我们回顾性分析了5100例70 - 80岁的前列腺癌患者,他们选择了放射治疗(外置放疗、近距离放疗或联合放疗)。收集了种族、前列腺特异性抗原值、直肠指检(DRE)结果和GSS的数据。患者进一步按年龄细分为70 - 75岁和76 - 80岁两类,并按时间段:2006-2010年和2011-2015年。在70 - 75岁的患者中,1426例患者的GSS为6(41%),2042例患者的GSS为7 - 10(59%)。在76 - 80岁的患者中,553例GSS为6(34%),1079例GSS为7 - 10(66%)。在1432例DRE结果异常的患者中,376例GSS为6分(26%),1059例GSS为7 ~ 10分(74%)。根据我们对5100例前列腺癌患者的分析,我们确定70 - 80岁的患者中有61%患有高级别前列腺癌,70 - 75岁的患者中有59%患有高级别前列腺癌,76 - 80岁的患者中有66%患有高级别前列腺癌。由于活检对GSS 6患者的分级低估了50%,因此实际频率约为80%。在DRE结果异常的前列腺癌患者中,74%的GSS为7 - 10,如果考虑活检分级不高,则约为85%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Immunotherapy in Urological Tumors. Best of the 2019 AUA Annual Meeting: Highlights From the 2019 American Urological Association Annual Meeting, May 3-6, 2019, Chicago, IL. Evaluation and Management of Chronic Scrotal Content Pain-A Common Yet Poorly Understood Condition. Preserving Independent Urology: LUGPA's First Decade. The Effect of Local Antibiogram-based Augmented Antibiotic Prophylaxis on Infection-related Complications Following Prostate Biopsy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1